Wednesday, 29 October 2008
Mayor Menino will cut ribbon to this free ‘home away from home’ for cancer patients
The American Cancer Society, New England Division, will officially open the AstraZeneca Hope Lodge Center in Boston on Wednesday, October 29, from 11:00 a.m. to 1:00 p.m. Mayor Thomas M. Menino is scheduled to help cut the ribbon and officially welcome Hope Lodge to the city.
The Society received a $7 million naming gift from AstraZeneca, LP (NYSE: AZN). Located at 125 South Huntington Avenue, the AstraZeneca Hope Lodge Center in Boston is built on the site of the former Vincent Memorial Hospital, which first opened in 1907. With its 40 new and spacious private suites, shared cooking and dining facilities, library, screening room, and healing garden, the AstraZeneca Hope Lodge Center will enable the American Cancer Society to provide up to 14,600 free nights of temporary housing each year to hundreds of cancer patients and family members who must travel far from home to Boston for medical treatment. Currently, only 61 hospitality rooms are available in the city, while the number of patients needing such support continues to rise.
Hope Lodge guests will also receive free transportation to treatment, counseling, and other vital support services. In addition, the building will house an American Cancer Society Community Resource Center, available for the Society’s community programs and patient services, and to local community groups for gatherings.
“This new facility is the realization of a dream,” said Don Gudaitis, CEO of the New England Division of the American Cancer Society. “The AstraZeneca Hope Lodge Center in Boston will give hundreds more cancer patients access to high quality cancer care every year.”
This is the 28th Hope Lodge in the nation to be opened by the American Cancer Society. Situated close to Boston’s world-class medical institutions, the 50,000 square foot facility will be the third American Cancer Society Hope Lodge in New England. The Worcester Hope Lodge opened in 1986, and last January the Society opened a new Hope Lodge in Burlington, VT, on the campus of Fletcher Allen Health Care, replacing one that originally opened there in 1985.
The Hope Lodge in Boston campaign began four years ago; to date, more than $26 million has been raised by the volunteer Campaign Cabinet. The American Cancer Society still needs to raise another $1 million to complete the project. In 2004, the Dana-Farber Cancer Institute invested $2.5 million in the Lodge, followed in 2005 by gifts of $2 million each from Massachusetts General Hospital and Brigham & Women’s Hospital, the founding hospitals of Partners HealthCare. The combined investments of the three hospitals enabled the American Cancer Society to purchase the site, which overlooks a scenic portion of the Emerald Necklace along the Jamaicaway.
Four gifts of $1 million or more, as well as numerous six-figure gifts, have been received from individual philanthropists, organizations, and foundations committed to increasing access to state-of-the-art treatment for cancer patients living outside the greater Boston area.
According to Tony Zook, President and CEO of AstraZeneca LP, the company’s naming of the Hope Lodge in Boston is “a living example of how important it is for AstraZeneca to contribute to the communities in which we live and work.”
“Patients are at the center of everything we do at AstraZeneca,” Mr. Zook said. “With a 30-year history of discovering and developing some of the world's leading oncology products, AstraZeneca is committed to giving patients access to the medicines and care they need to live longer, healthier lives. The new AstraZeneca Hope Lodge Center in Boston will ensure that more patients can take advantage of the high-quality cancer care that Boston offers.”
With its U.S. headquarters in Wilmington, Delaware, AstraZeneca has its second largest U.S. presence in Massachusetts, with a major cancer research facility in Waltham and operations located in Westborough.
About American Cancer Society
The American Cancer Society is the nationwide community-based voluntary health organization dedicated to eliminating cancer as a major health problem by preventing cancer, saving lives and diminishing suffering from cancer, through research, education, advocacy and service. For information about cancer, call toll-free anytime 1.800.ACS.2345 or visit the American Cancer Society at www.cancer.org.
AstraZeneca is a major international healthcare business engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.35 billion dollar healthcare business with 12,200 employees committed to improving people’s lives. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
For more information visit www.astrazeneca-us.com.
|Joyce Gallagher Sullivan, American Cancer Society||508-270-4759|
|Kirsten Evraire, AstraZeneca||302-885-0435|